Target intelligence / Profile preview

Deficient Endogenous Enzyme

Molecular classification
Enzyme
01

Overview

A "deficient endogenous enzyme" describes any situation where an individual has insufficient activity or quantity of an essential naturally occurring human enzyme. This state is most frequently caused by inherited genetic mutations leading to loss-of-function alleles. The result is disruption in specific metabolic pathways—either through toxic build-up upstream from the block or lack of critical downstream products—which manifests as various clinical syndromes depending on the affected pathway. Examples include phenylketonuria (phenylalanine hydroxylase deficiency), Tay–Sachs disease (hexosaminidase A deficiency), mucopolysaccharidoses such as Hurler syndrome, and DNA repair disorders like xeroderma pigmentosum. Diagnosis relies on biochemical assays and genetic testing; treatment options depend on the specific disorder but may involve dietary management, replacement therapy with exogenous enzymes, or supportive care[1][2][3].

Other names
Enzyme deficiencyInborn error of metabolismCongenital enzyme deficiency
02

Mechanism of action

Varies depending on the specific deficient enzyme and therapeutic approach. Dietary management aims to reduce substrate accumulation. Enzyme replacement therapy provides exogenous enzyme to compensate for the deficiency. Substrate reduction therapy decreases the production of the substrate of the deficient enzyme. Chaperone therapy stabilizes misfolded enzymes.

03

Biological functions

CatalysisMetabolismCellular homeostasis
04

Disease associations

Inborn Errors of MetabolismLysosomal Storage DisordersMucopolysaccharidosesDNA Repair DisordersNeurodegenerative diseaseGenetic disorders
05

Safety considerations

Varied depending on the specific enzyme deficiencyPotential for immune reactions to enzyme replacement therapyLong-term complications from metabolic imbalancesTherapeutic challenges in crossing the blood-brain barrier for neurological disorders
06

Interacting drugs

Phenylalanine-restricted diet (for PKU)

3 more in the full profile.

07

Biomarkers

Substrate levelsProduct levelsEnzyme activity assaysGenetic testing for causative mutations

Beyond the preview

Go deeper on Deficient Endogenous Enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deficient Endogenous Enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call